A human whole blood model of LPS-mediated suppression of T cell activation

Medical Science Monitor

Volumn 9, Issue 3, 2003, Pages

  Yaqub, Sheraz ^a   Solhaug, Vigdis ^a   Vang, Torkel ^a   Solberg, Rigmor ^a   Aasen, Ansgar O ^b   Taskén, Kjetil ^a   Wang, Jacob E ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

cAMP; Endotoxin; Immunosuppression; PGE2; Rp 8 Br cAMPS; Sepsis

Indexed keywords

8 BROMO CYCLIC AMP; 8 BROMO CYCLIC AMP PHOSPHOROTHIOIC ACID; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 2; PHOSPHOROTHIOIC ACID DERIVATIVE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MODEL; SEPSIS; T LYMPHOCYTE ACTIVATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; SEPSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THIONUCLEOTIDES;

EID: 0037355219     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bone RC: The pathogenesis of sepsis. Ann Intern Med, 1991; 115: 457-69
2. Sayeed MM: Alterations in cell signaling and related effector functions in T lymphocytes in burn/trauma/septic injuries. Shock, 1996; 5: 157-66
3. Choudhry MA, Ahmad S, Thompson KD, Sayeed MM: T-lymphocyte Ca2+ signalling and proliferative responses during sepsis. Shock, 1994; 1: 267-72
4. Faist E. Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg, 1996; 20: 454-9
5. van Leeuwen JE, Samelson LE: T cell antigen-receptor signal transduction. Curr Opin Immnnol, 1999; 11: 242-8
6. Vang T, Torgersen KM, Sundvold V et al: Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med, 2001; 193: 497-507
7. Okada M, Nada S, Yamanashi Y et al: CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J Biol Chem, 1991; 266: 24249-52
8. Bergman M, Mustelin T, Oetken C et al: The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and clown regulates its catalytic activity. EMBO J, 1992; 11: 2919-24
9. Chow LM, Fournel M, Davidson D, Veillette A: Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature, 1993; 365: 156-60
10. Torgersen KM, Vang T, Abrahamsen H et al: Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal, 2002: 14: 1-9
11. Choudhry MA, Ahmad S, Sayeed MM: Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis. Infect Immun, 1995; 63: 3101-5
12. Faist E, Mewes A, Strasser T et al: Alteration of monocyte function following major injury. Arch Surg, 1988; 123: 287-92
13. Choudhry MA, Fazal N, Namak SY et al: PGE2 suppresses intestinal T cell function in thermal injury: a cause of enhanced bacterial translocation. Shock, 2001; 16: 183-8
14. Faist E, Mewes A, Baker CC et al: Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma, 1987; 27: 837-48
15. Phipps RP, Stein SH, Roper RL: A new view of prostaglandin E regulation of the immune response. Immunol. Today, 1991; 12: 349-52
16. Minakuchi R, Wacholtz MC, Davis LS, Lipsky PE: Delineation of the mechanism-of-inhibition of human T cell activation by PGE2. J Immunol, 1990; 147: 2616-25
17. Ertel W, Morrison MH, Meldrum DR et al: Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res, 1992; 53: 55-61
18. Faist E, Ertel W, Cohnert T et al: Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma, 1990; 30: 8-17
19. Strong VE, Mackrell PJ, Concannon EM et al: Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival. Shock, 2000; 14: 374-9
20. Bowers GJ, MacVittie TJ, Hirsch EF et al: Prostanoid production by lipopolysaccharide-stimulated Kupffer cells. J Surg Res, 1985; 38: 501-8
21. Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev, 1999; 79: 1193-226
22. Kammer GM: The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today, 1988; 9: 222-9
23. Anastassiou ED, Paliogianni F, Balow JP et al: Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol, 1992; 148: 2845-52
24. Choudhry MA, Uddin S, Sayeed MM: Prostaglandin E2 modulation of p59fyn tyrosine kinase in T lymphocytes during sepsis. J Immunol, 1998; 160: 929-35
25. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest, 1997; 112: 235-43
26. Wang JE, Solberg R, Okkenhaug C et al: Cytokine modulation in experimental endotoxemia: characterization of an ex vivo whole blood model. Eur Surg Res, 2000; 32: 65-73
27. Luhm J, Kirchner H, Rink L: One-way synergistic effect of low superantigen concentrations on lipopolysaccharide-induced cytokine production. J. Interferon Cytokine Res, 1997; 17: 229-38
28. Oberholzer A, Feilner A, Hentze H et al: Sepsis after severe injury interrupts caspase-dependent processing of interleukin-18. J Trauma, 2000; 49: 11-6
29. Asai K, Hiki N, Mimura Y et al: Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock, 2001; 16: 340-3
30. Aandahl EM, Aukrust P, Skalhegg BS et al: Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J, 1998; 12: 855-62
31. Shimazu R, Akashi S, Ogata H et al: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med, 1999; 189: 1777-82
32. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal, 2001; 13: 85-94
33. Aukrust P, Aandahl EM, Skalhegg BS et al: Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. J Immunol, 1999; 162: 1178-85
34. Kammer GM: High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arthritis Rheum, 1999; 42: 1458-65
35. Kammer GM, Stein RL: T lymphocyte immune dysfunctions in systemic lupus erythematosus. J Lab Clin Med, 1990; 115: 273-82
36. Kammer GM, Khan IU, Kammer JA et al: Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: 11. Abnormal isozyme kinetics. J Immunol, 1996; 157: 2690-8
37. Kelly JL, O'Suilleabhain CB, Soberg CC et al: Severe injury triggers antigen-specific T-helper cell dysfunction. Shock, 1999; 12: 39-45
38. Brandtzaeg P, Osnes L, Ovstebo R et al: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med, 1996; 184: 51-60
39. Junger WG, Hoyt DB, Redl H et al: Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors. Shock, 1995; 3: 173-8
40. Ahmad S, Choudhry MA, Shankar R, Sayeed MM: Transforming growth factor-beta negatively modulates T-cell responses in sepsis. FEBS Lett, 1997; 402: 213-8
41. Moore KW, O'Garra A, de Waal MR et al: Interleukin-10. Annu Rev Immunol, 1993; 11: 165-90
42. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med, 2002; 30: 58-63
43. Ayala A, Chung CS, Song GY, Chaudry IH: IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine, 2001; 14: 37-48
44. Choudhry MA, Abroad S, Ahmed Z, Sayeed MM: Prostaglandin E2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis. Immunol Lett, 1999; 67: 125-30
45. Matsuguchi T, Takagi K, Musikacharoen T, Yoshikai Y: Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood, 2000; 95: 1378-85
46. Triantafilou K, Triantafilou M, Dedrick RL: A CD14-independent LPS receptor cluster. Nat Immunol, 2001; 2: 338-45
47. Samelson LE, Phillips AF, Luong ET, Klausner RD: Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci, 1990; 87: 4358-62
48. Choudhry MA, Ahmed Z, Sayeed MM: PGE(2)-mediated inhibition of T cell p59(fyn) is independent of cAMP. Am. J. Physiol, 1999; 277: 302-309
49. Veillette A, Bookman MA, Horak EM, Bolen JB: The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell, 1988; 55: 301-8
50. Denny MF, Patai B, Straus DB: Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn Mol Cell Biol, 2000; 20: 1426-35